Conduit Pharmaceuticals Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/12/2024 | Q2 2024 | -$0.07 | $604.34 M | |||
05/02/2024 | Q1 2024 | -$0.05 | $535.68 M | |||
12/30/2023 | Q4 2023 | $0.02 | $0 | |||
09/29/2023 | Q3 2023 | $0.03 | $0 | |||
06/29/2023 | Q2 2023 | -$0.40 | $0 | |||
03/30/2023 | Q1 2023 | -$0.59 | $0 | |||
12/30/2022 | Q4 2022 | -$0.18 | $0 | |||
09/29/2022 | Q3 2022 | -$0.01 | $0 | |||
06/28/2022 | Q2 2022 | -$0.01 | $0 | |||
03/30/2022 | Q1 2022 | -$0.00 | $0 | |||
12/29/2021 | Q4 2021 | -$0.00 | $0 |
Conduit Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Conduit Pharmaceuticals Inc.'s earnings date?
Conduit Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 11th, 2024 based off last year's report dates.
-
How can I listen to Conduit Pharmaceuticals Inc.'s earnings conference call?
The conference call for Conduit Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Conduit Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Conduit Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much profit does Conduit Pharmaceuticals Inc. generate each year?
Conduit Pharmaceuticals Inc. (:CDT) has a recorded net income of $0. Conduit Pharmaceuticals Inc. has generated $-0.008 earnings per share over the last four quarters.
-
What is Conduit Pharmaceuticals Inc.'s price-to-earnings ratio?
Conduit Pharmaceuticals Inc. (:CDT) has a price-to-earnings ratio of -1.78 and price/earnings-to-growth ratio is -0.02.